Urine cytology in the detection of bladder cancer: a critical approach
- PMID: 2074504
- DOI: 10.1097/00043764-199009000-00012
Urine cytology in the detection of bladder cancer: a critical approach
Abstract
Bladder cancer is composed of a group of tumors heterogeneous with respect to configuration, degree of differentiation, and biological course. Lethal and nonlethal forms of the disease exist. The nonlethal forms of cancer are generally well differentiated and not readily detected by voided urine cytology. The lethal form of cancer is accurately detected by voided urine cytology in symptomatic patients, but current evidence indicates a very short preclinical phase for most cases. A screening program should concentrate on detection of the lethal form of bladder cancer.
Similar articles
-
The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms.J Urol. 1997 Dec;158(6):2102-6. doi: 10.1016/s0022-5347(01)68167-9. J Urol. 1997. PMID: 9366322 Clinical Trial.
-
Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.J Urol. 2002 Aug;168(2):465-9. J Urol. 2002. PMID: 12131289
-
Voided urine flow cytometry in screening high-risk patients for the presence of bladder cancer.J Occup Med. 1990 Sep;32(9):894-7. doi: 10.1097/00043764-199009000-00028. J Occup Med. 1990. PMID: 2074515
-
Current status of urinary cytology in the evaluation of bladder neoplasms.Hum Pathol. 1990 Sep;21(9):886-96. doi: 10.1016/0046-8177(90)90171-z. Hum Pathol. 1990. PMID: 2203672 Review.
-
Detection of bladder tumors by immunostaining of the Lewis X antigen in cells from voided urine.Urology. 1995 Aug;46(2):173-7. doi: 10.1016/s0090-4295(99)80189-7. Urology. 1995. PMID: 7624989 Review.
Cited by
-
A Protocol for Organoids from the Urine of Bladder Cancer Patients.Cells. 2023 Aug 31;12(17):2188. doi: 10.3390/cells12172188. Cells. 2023. PMID: 37681920 Free PMC article.
-
The role of nuclear matrix protein 22 in the detection of persistent or recurrent transitional-cell cancer of the bladder.World J Urol. 1997;15(2):107-11. doi: 10.1007/BF02201981. World J Urol. 1997. PMID: 9144900 Review.
-
ProEx C as Diagnostic Marker for Detection of Urothelial Carcinoma in Urinary Samples: A Review.Int J Med Sci. 2017 Apr 21;14(6):554-559. doi: 10.7150/ijms.17890. eCollection 2017. Int J Med Sci. 2017. PMID: 28638271 Free PMC article. Review.
-
The influence of urine cytology on our practice.Urol Ann. 2012 May;4(2):80-3. doi: 10.4103/0974-7796.95550. Urol Ann. 2012. PMID: 22629001 Free PMC article.
-
Changing Pattern of Bladder Cancer Cytology. (Haynal Imre University Experience).Pathol Oncol Res. 1997;3(1):47-50. doi: 10.1007/BF02893353. Pathol Oncol Res. 1997. PMID: 11173625
MeSH terms
LinkOut - more resources
Full Text Sources
Medical